# Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive Nephrectomy

> **NCT05941169** · NA · NOT_YET_RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 750 (estimated)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **PROCEDURE:** Cytoreductive Nephrectomy

## Key facts

- **NCT ID:** NCT05941169
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2030-04-01
- **Final completion:** 2031-04-01
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2023-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05941169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05941169, "Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive Nephrectomy". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT05941169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*